Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Cardiovascular Imaging Reports
Erschienen in: Current Cardiovascular Imaging Reports 7/2017

01.07.2017 | Plaque Imaging (V Dilsizian and T Schindler, Section Editors)

Imaging the Coronary Artery Plaque: Approaches, Advances, and Challenges

verfasst von: Natasha Mamdani, Brian Tung, Ying Wang, Farouc A. Jaffer, Ahmed Tawakol

Erschienen in: Current Cardiovascular Imaging Reports | Ausgabe 7/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Atherosclerosis is a major cause of morbidity and mortality in the world, largely due to the disruption of high-risk plaques (HRP). Understanding how best to identify HRP, using imaging, has the potential to improve assessment of cardiovascular disease (CVD) risk and facilitate better targeting of care to patients.

Recent Findings

Technological advances have been made across several imaging modalities, which provide opportunities to image HRP. Advances in computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), intravascular ultrasound (IVUS), optical coherence tomography (OCT), and near-infrared spectroscopy (NIRS) target multiple features of HRP.

Summary

A growing number of studies have demonstrated their utility in assessing risk and guiding therapeutic interventions. While opportunities exist today to employ HRP imaging, further studies are needed to assess the value of imaging HRP to refine CVD risk and target therapeutics.
Literatur
1.
Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med. 1992;326:242–50.CrossRefPubMed
2.
Nabel EG, Braunwald E. A tale of coronary artery disease and myocardial infarction. N Engl J Med. 2012;366:54–63.CrossRefPubMed
3.
Dweck MR, Puntmann VO, Vesey AT, Fayad ZA, Nagel E. MR imaging of coronary arteries and plaques. J Am Coll Cardiol Img. 2016;9(3):306–16.CrossRef
4.
Batty JA, Subba S, Luke P, Gigi LWC, Sinclair H, Kunadian V. Intracoronary imaging in the detection of vulnerable plaques. Current Cardiology Reports. 2016;18(3):28.CrossRefPubMedPubMedCentral
5.
Ryan TJ. The coronary angiogram and its seminal contributions to cardiovascular medicine over five decades. Circulation. 2002;106(6):752–6.CrossRefPubMed
6.
Kolodgie FD, Virmani R, Burke AP, et al. Pathologic assessment of the vulnerable human coronary plaque. Heart. 2004;90:1385–91
7.
Bentzon JF, Otsuka F, Virmani R, Falk E. Mechanisms of plaque formation and rupture. Circulation. 2014;114(12):1852–66.CrossRef
8.
Shapiro E, Bush D, Motoyama S, Virmani R, Narula J. Imaging of vulnerable atherosclerotic plaques. In: Budoff M, Achenbach S, Narula J, editors. Atlas of Cardiovascular Computed Tomography. Philadel- phia, PA: Current Medicine Group LLC; 2007. p. 119–38.
9.
Narula J, Garg P, Achenbach S, Motoyama S, Virmani R, Strauss HW. Arithmetic of vulnerable plaques for noninvasive imaging. Nat Clin Pract Cardiovasc Med. 2008;5(Suppl 2):2–10.CrossRef
10.
Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol. 2006;47:C13–8.CrossRefPubMed
11.
Pozo E, Agudo-Quilez P, Rojas-González A, Alvarado T, Olivera MJ, Jiménez-Borreguero LJ, et al. Noninvasive diagnosis of vulnerable coronary plaque. World J Cardiol. 2016;8(9):520.CrossRefPubMedPubMedCentral
12.
Jaffer FA, Libby P, Weissleder R. Molecular and cellular imaging of atherosclerosis: emerging applications. J Am Coll Cardiol. 2006;47(7):1328–38.CrossRefPubMed
13.
Miao C, Chen S, Macedo R, et al. Positive remodeling of the coronary arteries detected by magnetic resonance imaging in an asymptomatic population. J Am Coll Cardiol. 2009;53:1708–15.CrossRefPubMedPubMedCentral
14.
Narula J, Strauss HW. The popcorn plaques. Nat Med. 2007;13(5):532–4.
15.
Falk E, Nakano M, Bentzon JF, et al. Update on acute coronary syndromes: the pathologists. Eur Heart J. 2013;34:719.CrossRefPubMed
16.
Burke AP, Farb A, Malcom GT, et al. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med. 1997;336:1276.CrossRefPubMed
17.
18.
Janoudi A, Shamoun FE, Kalavakunta JK, et al. Cholesterol crystal induced arterial inflammation and destabilization of atherosclerotic plaque. Eur Heart J. 2016;37:1959.CrossRefPubMed
19.
Roijers RB, Debernardi N, Cleutjens JP, et al. Micro-calcifications in early intimal lesions of atherosclerotic human coronary arteries. Am J Pathol. 2011;178(6):2879–87.CrossRefPubMedPubMedCentral
20.
Shah NR, Coulter SA. An evidence-based guide for coronary calcium scoring in asymptomatic patients without coronary heart disease. Annual Symposium on Risk, Diagnosis and Treatment of Cardiovascular Disease in Women. Texas Heart Institute, Houston. 2011;39(2):240–2.
21.
Budoff MJ, Young R, Lopez VA, et al. Progression of coronary calcium and incident coronary heart disease events: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2013;61(12):1231e9.CrossRef
22.
Keelan PC, Bielak LF, Ashai K, et al. Long-term prognostic value of coronary calcification detected by electron-beam computed tomography in patients undergoing coronary angiography. Circulation. 2001;104:412–7.CrossRefPubMed
23.
Wong ND, Hsu JC, Detrano RC, Diamond G, Eisenberg H, Gardin JM. Coronary artery calcium evaluation by electron beam computed tomography and its relation to new cardiovascular events. Am J Cardiol. 2000;86:495–8.CrossRefPubMed
24.
Arad Y, Spadaro LA, Goodman K, Newstein D, Guerci AD. Prediction of coronary events with electron beam computed tomography. J Am Coll Cardiol. 2000;36:1253–60.CrossRefPubMed
25.
Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2010;22:2748–64.
26.
Detrano R, Guerci AD, Carr JJ, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med. 2008;358:1336–45.CrossRefPubMed
27.
Greenland P, LaBree L, Azen SP, et al. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA. 2004;291:210–5.CrossRefPubMed
28.
Lakoski SG, Greenland P, Wong ND, et al. Coronary artery calcium scores and risk for cardiovascular events in women classified as “low risk” based on Framingham risk score: the Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med. 2007;167:2437–42.CrossRefPubMed
29.
Polonsky TS, McClelland RL, Jorgensen NW, et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA. 2010;303:1610–6.CrossRefPubMedPubMedCentral
30.
Nasir K, Bittencourt MS, Blaha MJ, et al. Implications of coronary aratery calcium testing among statin candidates according to the American College of Cardiology/American Heart Association cholesterol management guidelines. J Am Coll Cardiol. 2015;66(15):1657–68.CrossRefPubMed
31.
Goff DC, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American college of cardiology/ American heart association task force on practice guidelines. Circulation. 2014;129:S49–73.CrossRefPubMed
32.
33.
Motoyama S, Kondo T, Sarai M, et al. Multislice computed topographic characteristics of coronary lesions in acute coronary syndromes. J Am Coll Cardiol. 2007;50:319–26.CrossRefPubMed
34.
You S, Sun JS, Park SY, Baek Y, Kang DK. Relationship between indexed epicardial fat volume and coronary plaque volume assessed by cardiac multidetector CT. Medicine. 2016;95(27):e4164.CrossRefPubMedPubMedCentral
35.
Narula J, Achenbach S. Napkin-ring necrotic cores: defining circumferential extent of necrotic cores in unstable plaques. JACC Cardiovasc Imaging. 2009;2(12):1436–8.CrossRefPubMed
36.
Maurovich-Horvat P, Hoffmann U, Vorpahl M, Nakano M, Virmani R, Alkadhi H. The napkin-ring sign: CT signature of high-risk coronary plaques? JACC Cardiovasc Imaging. 2010;3(4):440–4.CrossRefPubMed
37.
Stolzmann P, Subramanian S, Abdelbaky A, Maurovich-Horvat P, Scheffel H, Tawakol A, et al. Complementary value of cardiac FDG PET and CT for the characterization of atherosclerotic disease. Radiographics. 2011;31(5):1255–69.CrossRefPubMed
38.
Hamed Emami, Richard A.P. Takx, Thomas Mayrhofer, et al. Nonobstructive coronary artery disease by coronary CT angiography improves risk stratification and allocation of statin therapy. J Am Coll Cardiol Img. 2017.
39.
40.
Danad I, Hartaigh BO, Min JK. Dual-energy computed tomography for detection of coronary artery disease. Expert Rev Cardiovasc Ther. 2015;13(12):1345–56.CrossRefPubMedPubMedCentral
41.
Pursnani A, Narang A, Edelman R. Cardiac computed tomography and magnetic resonance imaging: complementary or competing? EuroIntervention. 2016;12(X).
42.
Fayad ZA, Fuster V, Fallon JT, et al. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation. 2000;102:506–10.CrossRefPubMed
43.
Watanabe Y, Nagayama M, Suga T, et al. Characterization of atherosclerotic plaque of ca- rotid arteries with histopathological correlation: vascular wall MR imaging vs. color Doppler ultrasonography (US). J Magn Reson Imaging. 2008;28:478–85.CrossRefPubMed
44.
Pedersen SF, Thrysoe SA, Paaske WP, et al. Determination of edema in porcine coronary arteries by T2 weighted cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2011;13:52.CrossRefPubMedPubMedCentral
45.
Phinikaridou A, Andia ME, Passacquale G, et al. Noninvasive MRI monitoring of the effect of interventions on endothelial permeability in murine atherosclerosis using an albumin-binding contrast agent. J Am Heart Assoc. 2013;2(5):e000402.CrossRefPubMedPubMedCentral
46.
Tang TY, Howarth SP, Miller SR, et al. The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) study. Evaluation using ultrasmall supermagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. J Am Coll Cardiol. 2009;53(22):2039–50.CrossRefPubMed
47.
Joseph P, Tawakol A. Imaging atherosclerosis with positron emission tomography. Eur Heart J. 2016;37(39):2974–80.CrossRefPubMed
48.
Fuster V, Lewis A. Conner memorial lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology (erratum Circulation 1995;91:256). Circulation. 1994;90:2126–46.CrossRefPubMed
49.
Muller JE, Abela GS, Nesto RW, Tofler GH. Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontier. J Am Coll Cardiol. 1994;23:809–13.CrossRefPubMed
50.
Rogers IS, Nasir K, Figueroa AL, et al. Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina. JACC Cardiovasc Imaging. 2010;3:388–97.CrossRefPubMed
51.
Tawakol A, Migrino RQ, Hoffmann U, et al. Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol. 2005;12:294–301.CrossRefPubMed
52.
Tawakol A, Migrino RQ, Bashian GG, et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol. 2006;48:1818–24.CrossRefPubMed
53.
Abdelbaky A, Corsini E, Figueroa AL, et al. Focal arterial inflammation precedes subsequent calcification in the same location: a longitudinal FDG-PET/CT study. Circ Cardiovasc Imaging. 2013;6(5):747–54.CrossRefPubMed
54.
Figueroa AL, Abdelbaky A, Truong QA, et al. Measurement of arterial activity on routine FDG PET/CT image improves prediction of risk of future CV events. J Am Coll Cardiol: Cardiovasc Imaging. 2013;6(12):1250–9.CrossRef
55.
Marnane M, Merwick A, Sheehan OC, et al. Carotid plaque inflammation on (18) F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence. Ann Neurol. 2012;71(5):709–18.CrossRefPubMed
56.
Williams G, Kolodny GM. Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet. AJR Am J Roentgenol. 2008;190(2):W151–6.CrossRefPubMed
57.
Singh P, Emami H, Subramanian S, et al. Coronary plaque morphology and the anti-inflammatory impact of atorvastatin: a multicenter 18F-Fluorodeoxyglucose positron emission tomographic/computed tomographic study. Circ Cardiovasc Imaging. 2016;9(12):e004195.CrossRefPubMedPubMedCentral
58.
Nitta Y, Tahara N, Tahara A, et al. Pioglitazone decreases coronary artery inflammation in impaired glucose tolerance and diabetes mellitus evaluation by FDG-PET/CT imaging. J Am Coll Cardiol Cardiovasc Imaging. 2013;6:1172–82.CrossRef
59.
Wykrzykowska J, Lehman S, Williams G, et al. Imaging of inflamed and vulnerable plaque in journal of nuclear cardiology wells and Ruddy: the dream of imaging coronary artery inflammation coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate. High-Fat Preparation J Nucl Med. 2009;50:563–8.PubMed
60.
• Tawakol A, Fayad ZA, Mogg R, et al. Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computer tomography feasibility study. J Am Coll Cardiol. 2013;62(10):909–17. This study demonstrates the utility of FDG-PET in detecting early treatment effects in patients with atherosclerosis. CrossRefPubMed
61.
Suda M, Kiriyama T, Ishihara K, Onoguchi M, Kobayashi Y,Sakurai M, et al. The high matrix acquisition technique for imaging of atherosclerotic plaque inflammation in fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography with time-of-flight: Phantom study. J Nucl Cardiol. 2016.
62.
Slomka PJ, Rubeaux M, Le Meunier L, Dey D, Lazewatsky JL, Pan T, Dweck MR, et al. Dual-gated motion-frozen cardiac PET with Flurpiridaz F 18. J Nucl Med. 2015;56:1876–81.CrossRefPubMed
63.
64.
• Dweck MR, Chow MW, Joshi NV, et al. Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology. J Am Coll Cardiol. 2012;59(7):1539–48. This study demonstrates the utility of 18F-sodium fluoride as a marker for detecting vulnerable plaque and recent plaque rupture. This finding is important in assessing the role of intervention. CrossRefPubMed
65.
Joshi NV, Vesey AT, Williams MC, et al. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Lancet. 2014;383:705–13.CrossRefPubMed
66.
Dalm VA, van Hagen PM, van Koetsveld PM, et al. Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells. Am J Physiol Endocrinol Metab. 2003;285(2):E344–53.CrossRefPubMed
67.
Armani C, Catalani E, Balbarini A, Bagnoli P, Cervia D. Expression, pharmacology, and functional role of somatostatin receptor subtypes 1 and 2 in human macrophages. J Leukoc Biol. 2007;81(3):845–55.CrossRefPubMed
68.
Pedersen SF, Sandholt BV, Keller SH, et al. 64Cu-DOTATATE PET/MRI for detection of activated macrophages in carotid atherosclerotic plaques: studies in patients undergoing endarterectomy. Arterioscler Thromb Vasc Biol. 2015;35(7):1696–703.CrossRefPubMedPubMedCentral
69.
Tawakol A, Singh P, Mojena M, et al. HIF-1alpha and PFKFB3 mediate a tight relationship between proinflammatory activation and anerobic metabolism in atherosclerotic macrophages. Arterioscler Thromb Vasc Biol. 2015;35(6):1463–71.CrossRefPubMedPubMedCentral
70.
Mateo J, Izquierdo-Garcia D, Badimon JJ, Fayad ZA, Fuster V. Noninvasive assessment of hypoxia in rabbit advanced atherosclerosis using (1)(8)F-fluoromisonidazole positron emission tomographic imaging. Circ Cardiovasc Imaging. 2014;7(2):312–20.CrossRefPubMedPubMedCentral
71.
van der Valk FM, Sluimer JC, Voo SA, et al. In vivo imaging of hypoxia in atherosclerotic plaques in humans. JACC Cardiovasc Imaging. 2015;8(11):1340–1.CrossRefPubMed
72.
Mintz GS. Clinical utility of intravascular imaging and physiology in coronary artery disease. J Am Coll Cardiol. 2014;64(2):207–22.CrossRefPubMed
73.
Hayat U, Thondapu V, Haq MAU, Foin N, Jang I-K, Barlis P. Optical coherence tomography to evaluate coronary stent implantation and complications. Coron Artery Dis. 2015;26:e55–68.CrossRefPubMed
74.
Konishi A, Shinke T, Otake H, et al. Serial optical coherence tomography evaluation at 6, 12, and 24 months after Biolimus A9- eluting biodegradable polymer-coated stent implantation. Can J Cardiol. 2015;31(8):980–8.CrossRefPubMed
75.
Elliott MR, Thrush AJ. Measurement of resolution in intravascular ultrasound images. Physiol Meas. 1996;17:259–65.CrossRefPubMed
76.
Brezinski ME, Tearney GJ, Weissman NJ, Boppart SA, Bouma BE, Hee MR, Weyman AE, Swanson EA, Southern JF, Fujimoto JG. Assessing atherosclerotic plaque morphology: comparison of optical coherence tomography and high frequency intravascular ultrasound. Heart. 1996;77:397–403.CrossRef
77.
Hoang V, Grounds J, Pham D, et al. Role of intracoronary plaque imaging with intravascular ultrasound, optical coherence tomography, and near-infrared spectroscopy in patients with coronary artery disease. Curr Atheroscler Rep. 2016;18:57.CrossRefPubMed
78.
Garcia-Garcia HM, Costa MA, Serruys PW. Imaging of coronary atherosclerosis: intravascular ultrasound. Eur Heart Journ. 2010;31:2456–69.CrossRef
79.
• Stone GW, Maehara A, Lansky AJ, et al. A prospective natural-history of coronary atherosclerosis. N Engl J Med. 2011;364:226–35. This trial demonstrates that after ACS, recurrent MACE were equally attributable to recurrence at the site of culprit lesions and to nonculprit lesions. While nonculprit lesions that were responsible for unanticipated events were frequently angiographically mild, most were thin-cap fibroatheromas or were characterized by a large plaque burden, a small luminal area, or some combination of these characteristics. CrossRefPubMed
80.
Okada K, Fearon WF, Luikart H, et al. Attenuated-signal plaque progression predicts long-term mortality after heart transplantation. J Am Coll Cardiol. 2016;68(4):382–92.CrossRefPubMed
81.
Tuzcu EM, Hobbs RE, Rincon G, Bott-Silverman C, DeFranco AC, Robinson K, et al. Occult and frequent transmission of atherosclerotic coronary disease with cardiac transplantation. Insights from intravascular ultrasound. Circulation. 1995;91:1706–13.CrossRefPubMed
82.
ACCF/AHA/SCAI Practice Guideline. ACCF/AHA/SCAI guideline for percutaneous coronary intervention: executive summary. Circulation. 2011;2011:2574–609.
83.
Maejima N, Hibi K, Saka K, et al. Morphological features of non-culprit plaques on optical coherence tomography and integrated backscatter intravascular ultrasound in patients with acute coronary syndromes. Eur Heart Jour- Cardiovascular Imaging. 2014;16:190–7.CrossRef
84.
Kawasaki M. In vivo quantitative tissue characterization of human coronary arterial plaques by use of integrated backscatter intravascular ultrasound and comparison with angioscopic findings. Circulation. 2002;105:2487–92.CrossRefPubMed
85.
Kawasaki M, Sano K, Okubo M, et al. Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound. J Am Coll Cardiol. 2005;45:1946–53.CrossRefPubMed
86.
Okubo M, Kawasaki M, Ishihara Y, et al. Development of integrated backscatter intravascular ultrasound for tissue characterization of coronary plaques. Ultrasound in med and bio. 2008;34:655–63.CrossRef
87.
Kato K, Yasutake M, Yonetsu T, et al. Intracoronary imaging modalities for vulnerable plaques. J Nippon Med Sch. 2011;78(6):340–51.CrossRefPubMed
88.
Obaid DR, Calvert PA, McNab D, et al. Identification of coronary plaque sub-types using virtual histology intravascular ultrasound is affected by inter-observer variability and differences in plaque definitions. Circ Cardiovasc Imaging. 2012;5:86–93.CrossRefPubMed
89.
Nair A, Kuban BD, Tuzcu EM, Schoenhagen P, Nissen SE, Vince DG. Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation. 2002;106:2200–6.CrossRefPubMed
90.
Rodriguez-Granillo GA, Garcia-Garcia HM, Mc Fadden EP, et al. In vivo intravascular ultrasound-derived thin-cap fibroatheroma detection using ultrasound radiofrequency data analysis. J Am Coll Cardiol. 2005;46:2038–42.CrossRefPubMed
91.
Nasu K, Tsuchikane E, Katoh O, et al. Accuracy of in vivo coronary plaque morphology assessment: a validation study of in vivo virtual histology compared with in vitro histopathology. J Am Coll Cardiol. 2006;47:2405–12.CrossRefPubMed
92.
Kawaguchi R, Oshima S, Jingu M, et al. Usefulness of virtual histology intravascular ultrasound to predict distal embolization for ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2007;50:1641–6.CrossRefPubMed
93.
Celeng C, Takx RA, Ferencik M, Maurovich-Horvat P. Non-invasive and invasive imaging of vulnerable coronary plaque. Trends in Cardiovascular Medicine. 2016;26(6):538–47.CrossRefPubMed
94.
Yabushita H, Bouma BE, Houser SL, et al. Characterization of human atherosclerosis by optical coherence tomography. Circulation. 2002;106:1640–5.CrossRefPubMed
95.
Lindsay AC, Choudhury RP. Form to function: current and future roles for atherosclerosis imaging in drug development. Nat Rev Drug Discov. 2008;7:517–29.CrossRefPubMed
96.
Jang IK, Bouma BE, Kang DH, et al. Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound. J Am Coll Cardiol. 2002;39:604.CrossRefPubMed
97.
Kubo T, Imanishi T, Takarada S, et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol. 2007;50:933–9.CrossRefPubMed
98.
Jang IK, Tearney GJ, MacNeill B, et al. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation. 2005;111:1551–5.CrossRefPubMedPubMedCentral
99.
Kume T, Akasaka T, Kawamoto T, et al. Assessment of coronary arterial plaque by optical coherence tomography. Am J Cardiol. 2006;97:1172–5.CrossRefPubMed
100.
Tearney GJ, Yabushita H, Houser SL, et al. Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography. Circulation. 2003;107:113–9.CrossRefPubMed
101.
Roleder T, Galougahi KK, Chin CY, Bhatti NK, Brilakis E, Nazif TM, et al. Utility of near-infrared spectroscopy for detection of thin-cap neoatherosclerosis. Eur Heart J Cardiovasc Imaging. 2016.
102.
Madder RD, Smith JL, Dixon SR, Goldstein JA. Composition of target lesions by near-infrared spectroscopy in patients with acute coronary syndrome versus stable angina. Circ Cardiovasc Interv. 2012;5:55–61.CrossRefPubMed
103.
Danek BA, Karatasakis A, Alame AJ, Nguyen-Trong P-KJ, Karacsonyi J, Rangan B, et al. Saphenous vein graft near-infrared spectroscopy imaging insights from the lipid core plaque association with clinical events near-infrared spectroscopy (ORACLE-NIRS) registry. Catheterization and Cardiovascular Interventions. 2016.
104.
Oemrawsingh RM, Cheng JM, Garcia-Garcia HM, et al. Near-infrared spectroscopy predicts cardiovascular outcome in patients with coronary artery disease. J Am Coll Cardiol. 2014;64(23):2510–8.CrossRefPubMed
Metadaten
Titel
Imaging the Coronary Artery Plaque: Approaches, Advances, and Challenges
verfasst von
Natasha Mamdani
Brian Tung
Ying Wang
Farouc A. Jaffer
Ahmed Tawakol
Publikationsdatum
01.07.2017
Verlag
Springer US
Erschienen in
Current Cardiovascular Imaging Reports / Ausgabe 7/2017
Print ISSN: 1941-9066
Elektronische ISSN: 1941-9074
DOI
https://doi.org/10.1007/s12410-017-9419-z

Neu im Fachgebiet Kardiologie

25.04.2024 | Hypotonie | Nachrichten

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 | Hypertonie | Nachrichten

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

24.04.2024 | Adipositas | Nachrichten

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 | ACC 2024 | Nachrichten

Komplette Revaskularisation bei Infarkt: Neue Studie setzt ein Fragezeichen
weitere anzeigen

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen